Title
|
|
|
|
Presence of gammaherpesvirus BoHV-4 in endometrial cytology samples is not associated with subclinical endometritis diagnosed at artificial insemination in dairy cows
| |
Author
|
|
|
|
| |
Abstract
|
|
|
|
In the past, bovine herpesvirus 4 (BoHV-4) has been suggested to be associated with metritis and endometritis. However, not many field studies investigated the association between BoHV-4 and subclinical endometritis (SCE). In the present study, the association between the intrauterine presence of BoHV-4 and SCE diagnosed during artificial insemination (AI) was examined on two dairy farms in Belgium. An immunoperoxidase monolayer assay (IPMA) and an enzyme-linked immuno sorbent assay (ELISA) were used to screen the serum for anti-BoHV-4 antibodies. A SYBR green based one step real time qPCR was used to detect and quantify BoHV-4 (ORF20) in nasal, uterine and vaginal samples collected at Al. A reverse transcription qPCR (RT-qPCR) was used to detect mRNA (gB) as proof of a productive BoHV-4 infection. BoHV-4 was detected in 39.4% (farm A)/23.8% (farm B) of the nasal samples, 48.5% (farm A)/19.0% (farm B) of the uterine samples and 51.5% (farm A)/42.9% (farm B) of the vaginal samples. Active replication was only detected in farm A in 38.5% of the BoHV-4 positive nasal samples and in 5.95% positive cases of the vaginal samples. The prevalence of SCE diagnosed at AI was 45.5% and 42.9% in farm A and farm B, respectively. The presence of SCE was associated with a reduced pregnancy outcome at artificial insemination (Al) (P < 0.001). The occurrence of SCE at AI was not associated with the presence of latent or productive BoHV4 infections in the uterus nor in the vagina and nose (P > 0.05). |
| |
Language
|
|
|
|
English
| |
Source (journal)
|
|
|
|
Veterinary microbiology. - Amsterdam
| |
Publication
|
|
|
|
Amsterdam
:
2019
| |
ISSN
|
|
|
|
0378-1135
| |
DOI
|
|
|
|
10.1016/J.VETMIC.2018.12.025
| |
Volume/pages
|
|
|
|
229
(2019)
, p. 130-137
| |
ISI
|
|
|
|
000457658900016
| |
Full text (Publisher's DOI)
|
|
|
|
| |
|